3 completed, 3 recruiting, 2 active not recruiting, 1 terminated. 10 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 3, Recruiting 3, Active not recruiting 2, Terminated 1, Unknown 1 |
| Phase 1 | 3 | Active not recruiting 1, Terminated 1, Unknown 1 |
Follow Hypogonadism, Male: new trials by email Literature Review of Hypogonadism, Male trials Research Report on Hypogonadism, Male
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRT as an Adjunctive ERAS Therapy in ESRD Patients Undergoing Kidney Transplantation Testosterone Replacement Therapy - Hypogonadism, Male, End Stage Renal Disease (ESRD) | Phase 1 / Phase 2 | Active not recruiting | University of California, Los Angeles | 50 | 2025-07-01 | 2025-12-17 |
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male | Phase 1 / Phase 2 | Unknown | University of Washington | 10 | 2024-06-01 | 2024-03-15 |
| Testosterone Treatment in Men With Chronic Kidney Disease Jatenzo Pill - Hypogonadism, Male, Kidney Disease, Chronic | Phase 2 | Recruiting | St. Louis University | 20 | 2022-03-15 | 2026-04-30 |
| Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism Testosterone Undecanoate 250 MG/ML, Placebo - Opioid Use, Pain | Phase 2 | Recruiting | Brigham and Women's Hospital | 150 | 2022-01-10 | 2026-07-27 |
| Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED], placebo - Hypogonadism, Male, Fatigue Syndrome, Chronic | Phase 2 | Recruiting | Seattle Institute for Biomedical and Clinical Research | 240 | 2021-03-22 | 2026-06-22 |
| Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency testosterone 1.62% gel, placebo gel - Hypogonadism, Male, Cancer | Phase 2 | Active not recruiting | Seattle Institute for Biomedical and Clinical Research | 230 | 2021-01-12 | 2026-07-06 |
| A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males TSX-011 - Hypogonadism, Hypogonadism, Male | Phase 1 / Phase 2 | Terminated | TesoRx Pharma, LLC | 9 | 2017-11-06 | 2019-05-16 |
| Anastrazole and Clomiphene to Evaluate Hypogonadal Symptoms and Erectile Function Anastrozole 1mg, Clomiphene Citrate 25mg, Placebo - Cap - Hypogonadism, Male | Phase 2 | Completed | Albany Medical College | 24 | 2015-04-02 | 2019-11-18 |
| Clomid in Men With Low Testosterone With and Without Prior Treatment Clomiphene - Hypogonadism, Male | Phase 2 | Completed | Phoenix VA Health Care System | 42 | 2012-10-01 | 2021-03-10 |
| 28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men Nanomilled testosterone, Nanomilled dutasteride, commercially available dutasteride - Hypogonadism, Hypogonadism, Male | Phase 2 | Completed | GlaxoSmithKline | 43 | 2006-10-01 | 2017-05-30 |
Eunuchism (10) · Hypogonadism (6) · Endocrine System Diseases (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Gonadal Disorders (1) · Kidney Failure, Chronic (1) · Neoplasms (1) · Pain (1) · Pituitary Diseases (1) · Renal Insufficiency, Chronic (1)
Endocrine System Diseases (9) · Gonadal Disorders (9) · Pathological Conditions, Signs and Symptoms (5) · Hypogonadism (4) · Chronic Disease (3) · Disease Attributes (3) · Pathologic Processes (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Nervous System Diseases (2) · Renal Insufficiency (2) · Signs and Symptoms (2) · Urogenital Diseases (2)
Testosterone (3) · testosterone undecanoate (3) · Clomiphene (2) · Anastrozole (1) · Curcumin (1) · Drug Evaluation (1) · Gels (1) · Testosterone Propionate (1) · relugolix (1)
Seattle Institute for Biomedical and Clinical Research (2) · Albany Medical College (1) · Brigham and Women's Hospital (1) · GlaxoSmithKline (1) · Phoenix VA Health Care System (1) · St. Louis University (1) · TesoRx Pharma, LLC (1) · University of California, Los Angeles (1) · University of Washington (1)
United States (8)
John Amory, MD (1) · Jose M Garcia, MD, PhD (1) · Michael Oefelein, MD (1) · Robert C Welliver, MD (1) · Robert R Edwards, PhD (1) · Sandeep Dhindsa, MD (1) · Shehzad Basaria, MD (1) · Sherman M Harman, MD, PhD (1)